<DOC>
	<DOCNO>NCT01003886</DOCNO>
	<brief_summary>This study aim assess safety , tolerability efficacy Doxazosin GITS Filipino patient diagnose Benign Prostatic Hyperplasia ( BPH ) usual clinical care set .</brief_summary>
	<brief_title>A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia ( BPH )</brief_title>
	<detailed_description>This open label study . All patient prescribe Doxazosin GITS enrol study .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<criteria>Subjects include must consistent approve label indication Doxazosin mesylate GITS Philippines , include adult male diagnose BPH , prescribe Doxazosin mesylate GITS . Subjects condition contraindicate Doxazosin mesylate GITS base approve labeling Philippines .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>post marketing surveillance Filipino benign prostatic hyperplasia BPH Doxazosin GITS</keyword>
</DOC>